Multicenter evaluation of different target volume delineation concepts in pediatric Hodgkin’s lymphoma
暂无分享,去创建一个
D. Georg | B. Knäusl | C. Lütgendorf-Caucig | R. Pötter | D. Georg | K. Dieckmann | L. Claude | J. Lindh | B. Knäusl | I. Fotina | E. Gallop-Evans | L. Claude | J. Lindh | T. Pelz | R. Pötter | K. Dieckmann | EuroNet-PHL RT Group | E. Gallop‐Evans | T. Pelz | I. Fotina | C. Lütgendorf-Caucig | R. Pötter
[1] R. Pötter,et al. Paediatric Hodgkin's disease. , 1999, European journal of cancer.
[2] B. Heijmen,et al. Geometrical uncertainties, radiotherapy planning margins, and the ICRU-62 report. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] C. Hess,et al. The Impact of Gross Tumor Volume (GTV) and Clinical Target Volume (CTV) Definition on the Total Accuracy in Radiotherapy , 2003, Strahlentherapie und Onkologie.
[4] Thomas Filleron,et al. Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition. , 2011, International journal of radiation oncology, biology, physics.
[5] T. Wiegel,et al. Second Malignancies in High‑Dose Areas of Previous Tumor Radiotherapy , 2010, Strahlentherapie und Onkologie.
[6] M. Stock,et al. Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy , 2012, Strahlentherapie und Onkologie.
[7] Vincenzo Valentini,et al. Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin’s disease , 2011, Strahlentherapie und Onkologie.
[8] R. Pötter,et al. High cure rates and reduced long-term toxicity in pediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Pediatric Hodgkin's Disease Study Group. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] A. Bitencourt,et al. Conformal radiotherapy for lung cancer: interobservers' variability in the definition of gross tumor volume between radiologists and radiotherapists , 2009, Radiation oncology.
[10] Richard Pötter,et al. Feasibility of CBCT-based target and normal structure delineation in prostate cancer radiotherapy: multi-observer and image multi-modality study. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[11] Randall K Ten Haken,et al. CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. , 2005, International journal of radiation oncology, biology, physics.
[12] H. Eich,et al. Quality control of involved-field radiotherapy for patients with early stage Hodgkin’s lymphoma based on a central prospective review , 2012, Strahlentherapie und Onkologie.
[13] H. Eich,et al. The Development of Quality Assurance Programs for Radiotherapy within the German Hodgkin Study Group (GHSG) , 2005, Strahlentherapie und Onkologie.
[14] W. Klapper,et al. Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] H. O. Wyckoff,et al. International Commission on Radiation Units and Measurements , 1975 .
[16] Icru. Prescribing, recording, and reporting photon beam therapy , 1993 .
[17] K. Ang,et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[18] E. Noordijk,et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[19] R. Fisher,et al. Measurement of lung tumor volumes using three-dimensional computer planning software. , 2002, International journal of radiation oncology, biology, physics.
[20] Melvin L. Griem,et al. Prescribing, Recording, and Reporting Photon Beam Therapy , 1994 .
[21] R. Gascoyne,et al. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] E. Noordijk,et al. The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[23] L. Gianolli,et al. PET-guided dose escalation tomotherapy in malignant pleural mesothelioma , 2011, Strahlentherapie und Onkologie.
[24] R. Pötter,et al. The Concept of the GPOH-HD 2003 Therapy Study for Pediatric Hodgkin's Disease: Evolution in the Tradition of the DAL/GPOH Studies , 2004, Klinische Padiatrie.
[25] S. Senan,et al. Involved-node radiotherapy to the mediastinum. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[26] E. Kouwenhoven,et al. Measuring the similarity of target volume delineations independent of the number of observers , 2009, Physics in medicine and biology.
[27] H. Eich,et al. Involved-Node Radiotherapy in Early-Stage Hodgkin’s Lymphoma , 2008, Strahlentherapie und Onkologie.
[28] R. Pötter,et al. Preliminary results of the multicenter trial GPOH-HD 95 for the treatment of Hodgkin's disease in children and adolescents: analysis and outlook. , 2003, Klinische Padiatrie.
[29] P. Lambin,et al. The Use of FDG-PET to Target Tumors by Radiotherapy , 2010, Strahlentherapie und Onkologie.